Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Antithymocyte globulin as the primary treatment for renal allograft rejection.

Antithymocyte globulin as the primary treatment for renal allograft rejection. Transplantation. 1983 Nov; 36(5):587-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.